The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 354:2596-2598 June 15, 2006 Number 24
NextNext

Retinol-Binding Protein 4, Insulin Resistance, and Type 2 Diabetes
Kenneth S. Polonsky, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Graham, T. E.
-PubMed Citation
The current pandemic of type 2 diabetes is closely associated with obesity and insulin resistance. It is therefore essential that we gain a greater understanding of the pathogenesis of these two conditions and develop new approaches for their prevention and treatment.

The physiological changes responsible for the clinical manifestations of type 2 diabetes have been well characterized and include the defective secretion of insulin, enhanced hepatic glucose production, resistance to the action of insulin in its target tissues (muscle, fat, and liver), and elevated levels of triglyceride-rich particles and free fatty acids. All these abnormalities are generally present in clinically . . . [Full Text of this Article]


Source Information

From the Department of Medicine, Washington University School of Medicine, St. Louis.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.